Issue 96, 2019

PMP–diketopiperazine adducts form at the active site of a PLP dependent enzyme involved in formycin biosynthesis

Abstract

ForI is a PLP-dependent enzyme from the biosynthetic pathway of the C-nucleoside antibiotic formycin. Cycloserine is thought to inhibit PLP-dependent enzymes by irreversibly forming a PMP–isoxazole. We now report that ForI forms novel PMP–diketopiperazine derivatives following incubation with both D and L cycloserine. This unexpected result suggests chemical diversity in the chemistry of cycloserine inhibition.

Graphical abstract: PMP–diketopiperazine adducts form at the active site of a PLP dependent enzyme involved in formycin biosynthesis

Supplementary files

Article information

Article type
Communication
Submitted
06 Sep 2019
Accepted
16 Oct 2019
First published
15 Nov 2019
This article is Open Access
Creative Commons BY license

Chem. Commun., 2019,55, 14502-14505

PMP–diketopiperazine adducts form at the active site of a PLP dependent enzyme involved in formycin biosynthesis

S. Gao, H. Liu, V. de Crécy-Lagard, W. Zhu, N. G. J. Richards and J. H. Naismith, Chem. Commun., 2019, 55, 14502 DOI: 10.1039/C9CC06975E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements